The Nordic AML Group (NAMLG) aim to foster excellence in research and clinical care in acute myeloid leukemia (AML) in the Nordic countries, by forming an active network of clinicians and basic and translational scientists with deep interest and experience in the field.
Photo: NASA
.
Take the opportunity to submit an abstract for the Nordic AML Meeting in Bergen. The best poster will receive a 750€ prize and official recognition from Acta Oncologica.
[News? Please, let us know via namlgewg@gmail.com.]
There was a well-attended NAMLG lunch meetng in Munich 2025-03-17. The meeting started with an update on ongoing NAMLG activities with a focus on the upcoming NAMLG meeting in Bergen.
After remarks from the sponsor, Servier, we had an update on the LD-VenEx study followed by an IIS study proposal.
Results from the Finnish VenEx trial (NCT04267081) have now been published in Blood. You can find the publication by using this link.
[Have an event? Please, let us know via namlgewg@gmail.com.]
The newly established Jebsen Centre for Myeloid Blood Cancer (c-myc) will have their first Annual c-myc Seminar as a full-day satellite to CCBIO’s 13th Annual Symposium and will showcase recent […]
Find out more »CCBIO has the pleasure of inviting you to the 13th CCBIO Annual Symposium May 13-14, and now, PREFINAL PROGRAM is available. To participate, please register within April 1. There will be a strong scientific […]
Find out more »The Educational Working Group is planning an "AML Course Day" in conjunction with the Nordic AML Meeting in Bergen 2025. The AML Course Day covers topics such as the current […]
Find out more »Save the dates for the upcoming Nordic AML Meeting in Bergen, Norway, 2025.
Find out more »Click here to add your own text
